Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. Arthrospira Platensis 内皮の炎症と単細胞の活性化を弱める

Arthrospira Platensis 内皮の炎症と単細胞の活性化を弱める

Ilaria Leone1, Valentino Costabile1, Giovanni Smaldone1

  • 1IRCCS SYNLAB SND, 80143 Naples, Italy.

International journal of molecular sciences
|August 28, 2025

関連する実験動画

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.1K
Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.0K

PubMed で要約を見る

まとめ
この要約は機械生成です。

アルトロスピラ・プラテンシス (スピルリナ) は,内皮細胞と免疫細胞の相互作用を調節することによって,抗炎症および抗動脈硬化作用を示す. この天然の栄養薬は 主要な分子経路をターゲットにすることで 動脈硬化症を予防する可能性を 示しています

科学分野:

  • 心血管研究
  • 免疫学
  • 栄養薬学

背景:

  • 心血管疾患 (CVD),特に冠動脈疾患 (CAD) は,世界中で主要な死因です.
  • 早期のバイオマーカーを特定し,薬学的補助剤を理解することは,CVDの予防に不可欠です.
  • アルトロスピラ・プラテンシス (スピルリナ) のような栄養薬は,血管の抗炎症作用により有望である.

研究 の 目的:

  • Arthrospira platensisの抗炎症性および抗動脈硬化性の可能性を調査する.
  • 内皮細胞と免疫細胞の相互作用に対するスピルリナの効果を明らかにする.
  • スピルリナの分子化合物を特定する

主な方法:

  • 内皮細胞とTHP-1単細胞系にインビトロ検査を行った.
  • スピルリナの分子組成を分析するために,バイオインフォマティックプロファイリングが利用されました.
  • 計算分析により,既知の治療薬に構造的に類似した化合物が特定されました.

主要な成果:

  • 炎症性サイトカインとVEGFA/ VEGFR2発現を減少させた.
  • スピルリナはTHP-1単細胞の活性化と結合を低下させた.
  • 特定されたスピルリナ化合物は,TLR9アゴニストと抗血管新生活性を持つ合成分子を構造的に模倣する.

結論:

  • アルトロスピラ・プラテンシスは,重要な抗炎症および抗動脈硬化能力を示しています.
  • スピルリナは,動脈硬化症の予防に役立つ,内皮細胞と免疫細胞の交響を調節する.
  • スピルリナは免疫系と血管新生系を標的とした化合物の天然源として機能し,転移の可能性を備えています.
キーワード:
NF-κBシグナリングVEGF経路について動脈硬化症内皮の炎症モノサイト粘着スピルリナ・プラテンシス

関連する実験動画

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.1K
Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.0K

関連する概念動画

Inflammation01:38

Inflammation

55.1K
Overview
55.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

12.4K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
12.4K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー